Fluvoxamine Maleate Tablets: U.S. Product Guide
Fluvoxamine maleate tablets are prescription medications in the United States. Current DailyMed labels identify 25 mg, 50 mg and 100 mg strengths and state “Rx only.”
Fluvoxamine and fluvoxamine maleate
Fluvoxamine is the active moiety, while U.S. tablet products are labeled as fluvoxamine maleate. The dosage strength on a product label should be read together with the exact generic name and dosage form. A product described simply as “fluvoxamine” in search results may not provide enough information to identify the manufacturer or package.
Current DailyMed records show fluvoxamine maleate tablets under ANDAs from multiple labelers and repackagers. One current label lists 25 mg, 50 mg and 100 mg coated tablets. Another 2026 label from American Health Packaging is sourced from an underlying manufacturer product and likewise identifies the medicine as a human prescription drug.
Generic product differences
Different generic fluvoxamine products can have different NDCs, tablet imprints, colors, inactive ingredients and package sizes. That matters when a refill changes appearance or when an insurer processes a different NDC. The pharmacy can confirm whether a changed-looking tablet is an equivalent product supplied by a different manufacturer.
A brand name sometimes associated historically with fluvoxamine is Luvox, but product research should not use a historical brand name as if it identified every current U.S. fluvoxamine tablet. The actual labeler and NDC are more reliable for identifying what will be dispensed.
Prescription and clinical context
U.S. fluvoxamine labeling includes psychiatric indications and carries the antidepressant boxed warning regarding suicidal thoughts and behaviors in certain younger patients. The full labeling also contains significant drug-interaction information.
Starting fluvoxamine, changing dose, stopping an SSRI or switching between antidepressants requires prescriber review because indication, age, other medications and individual risk factors matter.
What to compare before filling a prescription
Useful questions include the prescribed strength, whether the prescription is for immediate-release tablets or another formulation, which manufacturer or NDC the pharmacy expects to dispense, and whether the insurance plan has formulary or quantity rules. A patient who has a concern about an inactive ingredient can ask for the exact product label before filling.
Cost comparisons should use the same strength, quantity and product type. A cash price for 100 mg tablets cannot automatically be compared with an insurance copay for 50 mg tablets, and a price from an old online listing may no longer apply.
Valencia Town Center Pharmacy
Contact the pharmacy to confirm current availability, product identity and coverage for a specific prescription.
Current strengths and product matching
Current U.S. labels commonly list 25 mg, 50 mg and 100 mg tablets. A prescription should be matched to the exact strength and dosage form rather than to the name “fluvoxamine” alone. If the pharmacy changes generic supplier, the imprint and color can change even though the prescribed active ingredient and strength remain the same.
Interaction review is part of responsible dispensing
Fluvoxamine has clinically important drug interactions described in its full prescribing information. Product research should acknowledge that without trying to reproduce an incomplete interaction checker. The dispensing pharmacist can review the patient’s medication profile, while the prescriber determines whether treatment is appropriate.
That boundary is especially important for SSRI product research: helping a patient verify the product and coverage is useful; encouraging unsupervised switching or combining medicines is not.
For broader patient-facing information, see Medication & Pharmacy Resources.